AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35443277 — intervention group
Group type: EXPERIMENTAL
Intervention: Memory perfectionism
Number of subjects: 77
Study 33548743 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonics-based reading intervention program
Number of subjects: 48
Study 33099934 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg/3 weeks
Number of subjects: 106
Study 33099934 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg/3 weeks with primary surgery
Number of subjects: 106
Study 33099934 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg/3 weeks with secondary debulking surgery
Number of subjects: 106
Study 32246238 — intervention group
Group type: EXPERIMENTAL
Intervention: Triangular three-port (TTEP)
Number of subjects: 28
Study 32246238 — intervention group
Group type: COMPARATOR
Intervention: Midline three-port (MTEP)
Number of subjects: 28
Study 33008855 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-event regimen (2 pills per day)
Number of subjects: 48
Study 33008855 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-event regimen (3 pills per day)
Number of subjects: 48
Study 33008855 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-event regimen (4 pills per day)
Number of subjects: 48
Study 33008855 — intervention group
Group type: EXPERIMENTAL
Intervention: Chewable calcium supplements
Number of subjects: 48
Study 33008855 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based strategies and counseling
Number of subjects: 48
Study 36485007 — intervention group
Group type: EXPERIMENTAL
Intervention: Ripretinib 150 mg once daily
Number of subjects: 129
Study 36485007 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 33872715 — intervention group
Group type: EXPERIMENTAL
Intervention: Mohs micrographic surgery
Number of subjects: 48
Study 33872715 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged excision
Number of subjects: 48
Study 33872715 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 48
Study 32111803 — intervention group
Group type: EXPERIMENTAL
Intervention: MRI after neoadjuvant chemotherapy
Number of subjects: 55
Study 34903704 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 × 500 mg metronidazole and 3 × 1.5 g cefuroxime intravenously for 3 days starting on the day before RC
Number of subjects: 30
Study 34903704 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 30
Study 32991471 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity running exercise under hypoxia (fraction of inspired oxygen 14.5%)
Number of subjects: 21
Study 32991471 — intervention group
Group type: COMPARATOR
Intervention: High-intensity running exercise under normoxia (fraction of inspired oxygen 20.9%)
Number of subjects: 21
Study 32991471 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week hypoxic running exercise training program
Number of subjects: 21
Study 36273227 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwifery-led antenatal pelvic floor muscle exercises (PFME) intervention
Number of subjects: 1400
Study 36273227 — intervention group
Group type: COMPARATOR
Intervention: Standard antenatal care (control)
Number of subjects: 1400
Study 33752119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 0.5% plus clonidine (2 mcg/kg, maximum of 100 mcg)
Number of subjects: 50
Study 33752119 — intervention group
Group type: COMPARATOR
Intervention: Ropivacaine 0.5% plus normal saline
Number of subjects: 50
Study 32513334 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein diet (HP)
Number of subjects: 50
Study 32513334 — intervention group
Group type: COMPARATOR
Intervention: Standard protein diet (SP)
Number of subjects: 50
Study 34973284 — intervention group
Group type: EXPERIMENTAL
Intervention: PTC923 60 mg/kg
Number of subjects: 24
Study 34973284 — intervention group
Group type: EXPERIMENTAL
Intervention: PTC923 20 mg/kg
Number of subjects: 24
Study 34973284 — intervention group
Group type: COMPARATOR
Intervention: Sapropterin 20 mg/kg
Number of subjects: 24
Study 34973284 — intervention group
Group type: COMPARATOR
Intervention: PTC923 60 mg/kg vs. Sapropterin
Number of subjects: 24
Study 34973284 — intervention group
Group type: COMPARATOR
Intervention: PTC923 20 mg/kg vs. Sapropterin
Number of subjects: 24
Study 34973284 — intervention group
Group type: EXPERIMENTAL
Intervention: PTC923 60 mg/kg in classical PKU subjects
Number of subjects: 24
Study 34973284 — intervention group
Group type: EXPERIMENTAL
Intervention: PTC923 60 mg/kg cofactor responder analysis
Number of subjects: 24
Study 33383229 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Touch care management strategy
Number of subjects: 0
Study 33383229 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Tech care management strategy
Number of subjects: 0
Study 33383229 — intervention group
Group type: COMPARATOR
Intervention: Usual Care management strategy
Number of subjects: 0
Study 32421814 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleep Restriction Therapy (SRT)
Number of subjects: 56
Study 32421814 — intervention group
Group type: COMPARATOR
Intervention: Time in Bed Regularization (TBR)
Number of subjects: 56
Study 33585918 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Physical Activity (PA) program
Number of subjects: 1633
Study 33585918 — intervention group
Group type: COMPARATOR
Intervention: Health Education (HE) program
Number of subjects: 1633
Study 33585918 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratings of perceived exertion (RPE)
Number of subjects: 1633
Study 33081850 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular treatment (EVT)
Number of subjects: 726
Study 33081850 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment (control group)
Number of subjects: 726
Study 32933850 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist trigger
Number of subjects: 53
Study 35148946 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular revascularisation (ER)
Number of subjects: 240
Study 35148946 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercise therapy (SET)
Number of subjects: 240
Study 33878195 — intervention group
Group type: EXPERIMENTAL
Intervention: Low light levels (sudden reduction to mesopic, adapted mesopic, adapted mesopic with LED)
Number of subjects: 28
Study 33878195 — intervention group
Group type: EXPERIMENTAL
Intervention: Sudden mesopic condition
Number of subjects: 28
Study 33878195 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted mesopic condition
Number of subjects: 28
Study 33878195 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted mesopic with LED lighting system
Number of subjects: 28
Study 33878195 — intervention group
Group type: COMPARATOR
Intervention: AMD group
Number of subjects: 28
Study 33878195 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 28
Study 33290857 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral oxycodone
Number of subjects: 164
Study 33290857 — intervention group
Group type: COMPARATOR
Intervention: Parenteral morphine
Number of subjects: 164
Study 33290857 — intervention group
Group type: COMPARATOR
Intervention: Comparison between oxycodone and morphine
Number of subjects: 164
Study 33290857 — intervention group
Group type: COMPARATOR
Intervention: Adverse events
Number of subjects: 164
Study 36070636 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance Training (HIRT) for 6 months
Number of subjects: 51
Study 36070636 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 51
Study 36070636 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Resistance Training (HIRT)
Number of subjects: 51
Study 33413316 — intervention group
Group type: EXPERIMENTAL
Intervention: F18-choline PET/CT
Number of subjects: 58
Study 33413316 — intervention group
Group type: COMPARATOR
Intervention: Tc99m-sestaMIBI SPECT/CT
Number of subjects: 58
Study 35413476 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 home-based knee-extensor resistance exercise sessions/week
Number of subjects: 140
Study 35413476 — intervention group
Group type: COMPARATOR
Intervention: 4 home-based knee-extensor resistance exercise sessions/week
Number of subjects: 140
Study 35413476 — intervention group
Group type: COMPARATOR
Intervention: 6 home-based knee-extensor resistance exercise sessions/week
Number of subjects: 140
Study 33485369 — intervention group
Group type: EXPERIMENTAL
Intervention: rVSV?G‐ZEBOV‐GP vaccine (with and without booster dose at 56 days)
Number of subjects: 4789
Study 33485369 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad26.ZEBOV,MVA‐FN‐Filo vaccine regimen (Ad26.ZEBOV first dose, MVA‐FN‐Filo 56 days later)
Number of subjects: 4789
Study 33485369 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4789
Study 34580784 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention for 6 months
Number of subjects: 2051
Study 32374768 — intervention group
Group type: EXPERIMENTAL
Intervention: Probe-based confocal endomicroscopy with automatic segmentation algorithm
Number of subjects: 46
Study 32374768 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy lung areas)
Number of subjects: 46
Study 34999321 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron intake below average requirement of 5 mg/day in infants
Number of subjects: 766
Study 34999321 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher daily iron intake per body weight (mg/kg)
Number of subjects: 766
Study 34999321 — intervention group
Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 766
Study 34999321 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent consumption of milk products in toddlers
Number of subjects: 766
Study 34999321 — intervention group
Group type: EXPERIMENTAL
Intervention: Consumption of meat and fish
Number of subjects: 766
Study 34999321 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of gestation and growth
Number of subjects: 766
Study 34999321 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth in boys
Number of subjects: 766
Study 34999321 — intervention group
Group type: EXPERIMENTAL
Intervention: Faster growth in girls
Number of subjects: 766
Study 34702425 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital game
Number of subjects: 162
Study 34702425 — intervention group
Group type: EXPERIMENTAL
Intervention: Storybook
Number of subjects: 162
Study 34702425 — intervention group
Group type: EXPERIMENTAL
Intervention: Storybook and reward (stickers)
Number of subjects: 162
Study 34702425 — intervention group
Group type: COMPARATOR
Intervention: Portuguese Food Wheel Guide
Number of subjects: 162
Study 32450737 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation training using an M&T simulator
Number of subjects: 63
Study 32450737 — intervention group
Group type: COMPARATOR
Intervention: Control group (no simulation training)
Number of subjects: 63
Study 35353086 — intervention group
Group type: EXPERIMENTAL
Intervention: Definitive abutment
Number of subjects: 13
Study 35353086 — intervention group
Group type: COMPARATOR
Intervention: Multiple disconnections and reconnections of the abutment (control group)
Number of subjects: 13
Study 32489080 — intervention group
Group type: EXPERIMENTAL
Intervention: Kuntai Capsules combined with GnRH-a
Number of subjects: 1041
Study 32489080 — intervention group
Group type: COMPARATOR
Intervention: GnRH-a alone
Number of subjects: 1041
Study 35754106 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibudilast
Number of subjects: 52
Study 35754106 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52
Study 33355658 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic peritoneal lavage
Number of subjects: 199
Study 33355658 — intervention group
Group type: COMPARATOR
Intervention: Colon resection
Number of subjects: 199
Study 35748777 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM 10 mg
Number of subjects: 32
Study 35748777 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM 20 mg
Number of subjects: 32
Study 35748777 — intervention group
Group type: EXPERIMENTAL
Intervention: LEM 30 mg
Number of subjects: 32
Study 35748777 — intervention group
Group type: EXPERIMENTAL
Intervention: ZOL 30 mg
Number of subjects: 32
Study 35748777 — intervention group
Group type: EXPERIMENTAL
Intervention: SUV 40 mg
Number of subjects: 32
Study 32079487 — intervention group
Group type: EXPERIMENTAL
Intervention: Radioiodine treatment (131I)
Number of subjects: 56
Study 36479556 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based habit reversal training (MHRT)
Number of subjects: 160
Study 36479556 — intervention group
Group type: EXPERIMENTAL
Intervention: Habit reversal training (HRT)
Number of subjects: 160
Study 36479556 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducation and supportive therapy (PST)
Number of subjects: 160
Study 36479556 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural correlates of MHRT
Number of subjects: 160
Study 36479556 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural correlates of HRT and PST
Number of subjects: 160
Study 33298062 — intervention group
Group type: EXPERIMENTAL
Intervention: BDP/F/G
Number of subjects: 23
Study 33298062 — intervention group
Group type: COMPARATOR
Intervention: BDP/F
Number of subjects: 23
Study 35641000 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronically-assisted inspiratory muscle training (EIMT)
Number of subjects: 104
Study 35641000 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous breathing with T-piece
Number of subjects: 104
Study 35641000 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual EIMT
Number of subjects: 104
Study 33053005 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage followed by rest (G1)
Number of subjects: 101
Study 33053005 — intervention group
Group type: EXPERIMENTAL
Intervention: Massage followed by Reiki (G2)
Number of subjects: 101
Study 33053005 — intervention group
Group type: COMPARATOR
Intervention: Control (G3)
Number of subjects: 101
Study 35182194 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster dextrin (CDX)
Number of subjects: 10
Study 35182194 — intervention group
Group type: COMPARATOR
Intervention: Glucose (GLC)
Number of subjects: 10
Study 32933794 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized audiovisual education
Number of subjects: 124
Study 34600777 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderation messages with low-risk behaviors
Number of subjects: 476
Study 34600777 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderation messages with high-risk behaviors
Number of subjects: 476
Study 34600777 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence messages with low-risk behaviors
Number of subjects: 476
Study 34600777 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence messages with high-risk behaviors
Number of subjects: 476
Study 34600777 — intervention group
Group type: COMPARATOR
Intervention: Generic guidelines after full range of risk behaviors infographic
Number of subjects: 476
Study 34600777 — intervention group
Group type: COMPARATOR
Intervention: Generic guidelines after no risk behaviors infographic
Number of subjects: 476
Study 33819214 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose continuous ultrasound (3 sessions per week for 7 weeks)
Number of subjects: 30
Study 33819214 — intervention group
Group type: COMPARATOR
Intervention: Far-infrared treatment (3 sessions per week for 7 weeks)
Number of subjects: 30
Study 32785709 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin (10 mg/kg/d)
Number of subjects: 6859
Study 32785709 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid (5 mg/kg/d)
Number of subjects: 6859
Study 32785709 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin
Number of subjects: 6859
Study 32785709 — intervention group
Group type: COMPARATOR
Intervention: Isoniazid
Number of subjects: 6859
Study 32785709 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin among participants living with HIV
Number of subjects: 6859
Study 35138360 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative factors identified as statistically significant predictors of 10-year mortality
Number of subjects: 3102
Study 35138360 — intervention group
Group type: COMPARATOR
Intervention: Univariable models for mortality
Number of subjects: 3102
Study 34039209 — intervention group
Group type: EXPERIMENTAL
Intervention: Inpatient satisfaction scores
Number of subjects: 231
Study 34039209 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up satisfaction scores (4 to 6 weeks after discharge)
Number of subjects: 231
Study 34039209 — intervention group
Group type: EXPERIMENTAL
Intervention: Concordance between inpatient and follow-up satisfaction scores
Number of subjects: 231
Study 36172719 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative medicine (OMM) - 2 treatments
Number of subjects: 25
Study 36172719 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative medicine (OMM) - 1 treatment
Number of subjects: 25
Study 36172719 — intervention group
Group type: COMPARATOR
Intervention: Concussion-education - 2 sessions
Number of subjects: 25
Study 34406400 — intervention group
Group type: EXPERIMENTAL
Intervention: Mammography with ultrasonography
Number of subjects: 19213
Study 34406400 — intervention group
Group type: COMPARATOR
Intervention: Mammography alone
Number of subjects: 19213
Study 32710204 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperthermic IPEC of cisplatin (75, 100, and 120 mg/m2)
Number of subjects: 50
Study 32710204 — intervention group
Group type: COMPARATOR
Intervention: Normothermic IPEC of cisplatin (75, 100, and 120 mg/m2)
Number of subjects: 50
Study 32710204 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (75 mg/m2) with IPEC duration of 1-2 hours
Number of subjects: 50
Study 32710204 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (100 and 120 mg/m2) with IPEC duration of 1 hour
Number of subjects: 50
Study 32710204 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin (75, 100, and 120 mg/m2)
Number of subjects: 50
Study 33668075 — intervention group
Group type: EXPERIMENTAL
Intervention: Breath-hold (BH) scan and cine CT imaging sessions
Number of subjects: 14
Study 33053991 — intervention group
Group type: EXPERIMENTAL
Intervention: Adolescent gastric cancer patients
Number of subjects: 63
Study 34518254 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramipril 5 mg for a minimum of 12 weeks before surgery
Number of subjects: 0
Study 34518254 — intervention group
Group type: COMPARATOR
Intervention: Placebo for a minimum of 12 weeks before surgery
Number of subjects: 0
Study 32719760 — intervention group
Group type: EXPERIMENTAL
Intervention: 120-min ECI sessions
Number of subjects: 20
Study 32719760 — intervention group
Group type: COMPARATOR
Intervention: 90-min ECI sessions
Number of subjects: 20
Study 35553981 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Glucose Monitoring (CGM) with Levels software
Number of subjects: 25
Study 35553981 — intervention group
Group type: COMPARATOR
Intervention: Classic glucometer (Control)
Number of subjects: 25
Study 35553981 — intervention group
Group type: COMPARATOR
Intervention: Both CGM and Control groups
Number of subjects: 25
Study 33751727 — intervention group
Group type: EXPERIMENTAL
Intervention: Medications (bronchodilators and inhaled corticosteroids)
Number of subjects: 0
Study 33751727 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive strategies and treatments that alter the course of disease
Number of subjects: 0
Study 33751727 — intervention group
Group type: EXPERIMENTAL
Intervention: Understanding gender-based predictors of efficacy of therapeutic interventions
Number of subjects: 0
Study 33751727 — intervention group
Group type: EXPERIMENTAL
Intervention: Exploration of disease trajectories of other non-communicable diseases (NCD)
Number of subjects: 0
Study 33257417 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning prompt (calendar showing dates and prompting to select a date and time)
Number of subjects: 2362
Study 33257417 — intervention group
Group type: COMPARATOR
Intervention: Control (calendar showing dates of community health campaign)
Number of subjects: 2362
Study 33257417 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning prompt among men enrolled ≤40 days before campaigns
Number of subjects: 2362
Study 33257417 — intervention group
Group type: EXPERIMENTAL
Intervention: Planning prompt among men enrolled >40 days before campaigns
Number of subjects: 2362
Study 35459607 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured T2DM group education programme
Number of subjects: 367
Study 35459607 — intervention group
Group type: COMPARATOR
Intervention: Routine care (Control)
Number of subjects: 367
Study 34808726 — intervention group
Group type: EXPERIMENTAL
Intervention: onaBotulinum Toxin type A injection (100 units)
Number of subjects: 31
Study 34808726 — intervention group
Group type: COMPARATOR
Intervention: Control group (placebo)
Number of subjects: 31
Study 32804527 — intervention group
Group type: EXPERIMENTAL
Intervention: LGB discrimination
Number of subjects: 310
Study 32804527 — intervention group
Group type: EXPERIMENTAL
Intervention: LGB affirmation
Number of subjects: 310
Study 32804527 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 310
Study 35903663 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective use of lumbar drains (LD) during perioperative period
Number of subjects: 153
Study 34462241 — intervention group
Group type: EXPERIMENTAL
Intervention: Extreme learning machine network with particle swarm optimization
Number of subjects: 10060
Study 34462241 — intervention group
Group type: COMPARATOR
Intervention: Support vector machine
Number of subjects: 10060
Study 34462241 — intervention group
Group type: COMPARATOR
Intervention: Bayesian networks
Number of subjects: 10060
Study 34462241 — intervention group
Group type: COMPARATOR
Intervention: Various models for all syndromes
Number of subjects: 10060
Study 35965162 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Acetaminophen (1,000 mg)
Number of subjects: 162
Study 35965162 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous Hydromorphone (0.5 mg)
Number of subjects: 162
Study 32808693 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomly selected sites
Number of subjects: 0
Study 32808693 — intervention group
Group type: COMPARATOR
Intervention: Sites selected with site-selection bias
Number of subjects: 0
Study 36002801 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative interviews with retention staff
Number of subjects: 25
Study 36002801 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative interviews with recruitment staff
Number of subjects: 25